{"id":42586,"date":"2025-11-29T13:10:49","date_gmt":"2025-11-29T07:40:49","guid":{"rendered":"https:\/\/edunovations.com\/currentaffairs\/?p=42586"},"modified":"2025-11-29T13:10:52","modified_gmt":"2025-11-29T07:40:52","slug":"affordable-malaria-vaccine","status":"publish","type":"post","link":"https:\/\/edunovations.com\/currentaffairs\/international\/affordable-malaria-vaccine\/","title":{"rendered":"Affordable Malaria Vaccine: Gavi-UNICEF Deal Reduces R21\/Matrix-M Price"},"content":{"rendered":"\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_83 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/edunovations.com\/currentaffairs\/international\/affordable-malaria-vaccine\/#Affordable_malaria_vaccine_deal_by_Gavi_and_UNICEF_reduces_R21Matrix-M_cost_to_US_299_per_dose_aiming_to_vaccinate_7_million_children_and_improve_global_health_equity\" >Affordable malaria vaccine deal by Gavi and UNICEF reduces R21\/Matrix-M cost to US$ 2.99 per dose, aiming to vaccinate 7 million children and improve global health equity.<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/edunovations.com\/currentaffairs\/international\/affordable-malaria-vaccine\/#Gavi_UNICEF_Secure_Affordable_Malaria_Vaccine_Deal_%E2%80%94_What_It_Means\" >Gavi &amp; UNICEF Secure Affordable Malaria Vaccine Deal \u2014 What It Means<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/edunovations.com\/currentaffairs\/international\/affordable-malaria-vaccine\/#Why_This_News_is_Important\" >Why This News is Important<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/edunovations.com\/currentaffairs\/international\/affordable-malaria-vaccine\/#Historical_Context_The_Road_to_a_Malaria_Vaccine\" >Historical Context: The Road to a Malaria Vaccine<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/edunovations.com\/currentaffairs\/international\/affordable-malaria-vaccine\/#Key_Takeaways_from_Gavi-UNICEF_Malaria_Vaccine_Deal\" >Key Takeaways from Gavi-UNICEF Malaria Vaccine Deal<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/edunovations.com\/currentaffairs\/international\/affordable-malaria-vaccine\/#FAQs_Frequently_Asked_Questions\" >FAQs: Frequently Asked Questions<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/edunovations.com\/currentaffairs\/international\/affordable-malaria-vaccine\/#Some_Important_Current_Affairs_Links\" >Some Important Current Affairs Links<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Affordable_malaria_vaccine_deal_by_Gavi_and_UNICEF_reduces_R21Matrix-M_cost_to_US_299_per_dose_aiming_to_vaccinate_7_million_children_and_improve_global_health_equity\"><\/span>Affordable malaria vaccine deal by Gavi and UNICEF reduces R21\/Matrix-M cost to US$ 2.99 per dose, aiming to vaccinate 7 million children and improve global health equity.<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Gavi_UNICEF_Secure_Affordable_Malaria_Vaccine_Deal_%E2%80%94_What_It_Means\"><\/span>Gavi &amp; UNICEF Secure Affordable Malaria Vaccine Deal \u2014 What It Means<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><strong>New Pricing Agreement for Malaria Vaccine<\/strong><br>On 24 November 2025, Gavi, the Vaccine Alliance in partnership with UNICEF announced a landmark pricing deal for the malaria vaccine R21\/Matrix-M\u2122. Under this agreement, the price per dose of the vaccine will be reduced to <strong>US$ 2.99<\/strong> \u2014 a substantial decrease from the previous pricing. <\/p>\n\n\n\n<p>This cost reduction is enabled by innovative financing through International Finance Facility for Immunisation (IFFIm), which converts long-term donor pledges into immediate funds, allowing Gavi and UNICEF to act swiftly.<\/p>\n\n\n\n<p><strong>Expansion of Vaccine Access and Impact<\/strong><br>The agreement is expected to generate up to <strong>US$ 90 million in savings<\/strong> \u2014 savings that will enable procurement of <strong>30 million additional doses<\/strong> of the vaccine over the coming years.<\/p>\n\n\n\n<p>With these additional doses, Gavi and UNICEF target to fully vaccinate nearly <strong>7 million more children<\/strong> by around 2030. This move is a crucial step toward Gavi\u2019s broader goal of vaccinating <strong>50 million children<\/strong> against malaria by the end of the decade. <\/p>\n\n\n\n<p><strong>Context: Malaria\u2019s Global Burden<\/strong><br>Malaria remains among the world\u2019s deadliest diseases. In 2023 alone, there were an estimated <strong>263 million malaria cases<\/strong> globally, resulting in <strong>about 597,000 deaths<\/strong>, with the vast majority occurring in Africa \u2014 particularly among children under five years old. <\/p>\n\n\n\n<p>In many high-burden regions, access to prevention, treatment, and healthcare infrastructure is limited, making a vaccine-based approach especially critical.<\/p>\n\n\n\n<p><strong>What This Deal Represents for Global Health<\/strong><br>The agreement between Gavi and UNICEF is more than just a price cut. It signals a commitment to <em>vaccine equity<\/em>, sustainable access, and long-term market shaping. By making the R21\/Matrix-M vaccine broadly affordable, the deal helps ensure that countries \u2014 particularly low- and middle-income nations \u2014 can integrate malaria immunization into routine public health programmes. <\/p>\n\n\n\n<p>Moreover, the use of IFFIm\u2019s innovative financing underscores how financial tools can accelerate life-saving interventions, even when donor funding or international aid is uncertain. <\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-large\" id=\"Affordable-Malaria-Vaccine\"><img decoding=\"async\" src=\"data:image\/jpeg;base64,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\" alt=\"Affordable Malaria Vaccine\" title=\"Affordable Malaria Vaccine\"\/><figcaption class=\"wp-element-caption\">Affordable Malaria Vaccine<\/figcaption><\/figure>\n<\/div>\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Why_This_News_is_Important\"><\/span>Why This News is Important<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><strong>Tackling a Major Global Health Crisis<\/strong><br>Malaria is one of the deadliest infectious diseases globally, especially for young children in high-burden regions. The new pricing agreement dramatically lowers the cost barrier to vaccination, making it realistic for countries with limited resources to deploy the malaria vaccine at scale.<\/p>\n\n\n\n<p><strong>Potential to Save Millions of Lives<\/strong><br>By enabling vaccination of millions more children, this deal could significantly reduce childhood mortality and morbidity due to malaria. For many countries, especially in Africa, this could mean fewer hospitalizations, less disease burden, and stronger public-health resilience.<\/p>\n\n\n\n<p><strong>Promoting Equity and Access<\/strong><br>This agreement promotes vaccine equity \u2014 meaning access to life-saving vaccines is not limited to wealthy nations. It helps level the playing field for children in low-income countries who are disproportionately affected by malaria.<\/p>\n\n\n\n<p><strong>A Model of Innovative Financing &amp; Global Cooperation<\/strong><br>The use of IFFIm \u2014 turning long-term donor pledges into immediate funding \u2014 demonstrates how innovative financing mechanisms can accelerate global health interventions. It\u2019s a strong example of international cooperation, combining public-private partnerships, global institutions, and manufacturing capacity to serve vulnerable populations.<\/p>\n\n\n\n<p><strong>Implications for Future Global Health Strategy<\/strong><br>This deal may mark a turning point in malaria control efforts. With sustained support and scale-up, widespread vaccination could drastically reduce malaria incidence and fatalities. It also sets a precedent for how other vaccines (for malaria or different diseases) might be priced and distributed equitably in future.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Historical_Context_The_Road_to_a_Malaria_Vaccine\"><\/span>Historical Context: The Road to a Malaria Vaccine<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><strong>Long-standing Challenge of Malaria<\/strong><br>Malaria \u2014 caused by parasites transmitted by Anopheles mosquitoes \u2014 has plagued human societies for centuries. Despite decades of efforts involving mosquito control, bed nets, antimalarial drugs, and public-health campaigns, the disease remains endemic in many parts of Sub-Saharan Africa, South Asia, and other tropical regions.<\/p>\n\n\n\n<p><strong>Vaccine Development: From RTS,S to R21\/Matrix-M<\/strong><br>Vaccination against malaria has long been a difficult challenge due to the complex life cycle of the parasite. The first vaccine to gain real-world use was RTS,S\/AS01 (also known as Mosquirix), rolled out in pilot programmes starting around 2019 in select African countries under guidance of World Health Organization (WHO), with support from Gavi and partners.<\/p>\n\n\n\n<p>More recently, the R21\/Matrix-M vaccine was developed (with contributions from institutions including the Serum Institute of India) to improve efficacy, affordability, and scalability. As of 2024\u20132025, multiple African nations have begun introducing malaria vaccines into their routine immunization programmes \u2014 a major milestone in global malaria prevention efforts.<\/p>\n\n\n\n<p><strong>Role of Gavi and UNICEF in Scaling Up Vaccination<\/strong><br>Since its inception in 2000, Gavi \u2014 bringing together governments, global organizations, vaccine manufacturers, and financiers \u2014 has played a pivotal role in expanding access to vaccines in low-income countries. Over the years, it has helped immunize over a billion children and prevented millions of deaths. <\/p>\n\n\n\n<p>UNICEF, as one of the world\u2019s largest vaccine buyers and distributors, ensures vaccines reach children in need, working with national immunization programmes worldwide. <\/p>\n\n\n\n<p>The new 2025 agreement builds on this legacy \u2014 combining technical, financial, and logistic strengths to bring malaria vaccination to more children across Africa and other regions.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Key_Takeaways_from_Gavi-UNICEF_Malaria_Vaccine_Deal\"><\/span>Key Takeaways from Gavi-UNICEF Malaria Vaccine Deal<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>#<\/th><th>Key Takeaway<\/th><\/tr><\/thead><tbody><tr><td>1<\/td><td>The R21\/Matrix-M malaria vaccine dose will cost US$ 2.99 under the new Gavi-UNICEF agreement. <\/td><\/tr><tr><td>2<\/td><td>The deal is expected to generate up to US$ 90 million in savings, enabling procurement of 30 million additional vaccine doses.<\/td><\/tr><tr><td>3<\/td><td>Approximately 7 million more children worldwide could be fully vaccinated by around 2030 as a result of this agreement<\/td><\/tr><tr><td>4<\/td><td>The agreement is funded via the IFFIm mechanism, which converts long-term donor pledges into immediate cash, accelerating vaccine deployment. <\/td><\/tr><tr><td>5<\/td><td>This move marks a major step toward equitable global health, potentially reducing malaria cases and deaths, especially among children in high-burden countries.<\/td><\/tr><\/tbody><\/table><figcaption class=\"wp-element-caption\">Affordable Malaria Vaccine<\/figcaption><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"FAQs_Frequently_Asked_Questions\"><\/span>FAQs: Frequently Asked Questions<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><strong>1. What is the R21\/Matrix-M malaria vaccine?<\/strong><br>The R21\/Matrix-M vaccine is a next-generation malaria vaccine designed to protect children from Plasmodium falciparum, the most deadly malaria parasite. It improves upon earlier vaccines like RTS,S in efficacy and scalability.<\/p>\n\n\n\n<p><strong>2. How much will the malaria vaccine cost under the Gavi-UNICEF deal?<\/strong><br>The vaccine will be available at <strong>US$\u202f2.99 per dose<\/strong>, significantly reducing the cost for low- and middle-income countries.<\/p>\n\n\n\n<p><strong>3. How many children are expected to benefit from this deal?<\/strong><br>Around <strong>7 million additional children<\/strong> could be fully vaccinated by 2030 through this initiative.<\/p>\n\n\n\n<p><strong>4. What is the role of Gavi and UNICEF in malaria vaccination?<\/strong><br>Gavi provides funding, coordination, and market shaping for vaccines, while UNICEF ensures procurement and distribution to reach children in high-burden countries.<\/p>\n\n\n\n<p><strong>5. What is IFFIm, and how does it help malaria vaccination?<\/strong><br>The <strong>International Finance Facility for Immunisation (IFFIm)<\/strong> converts long-term donor pledges into immediate funds, enabling rapid vaccine procurement and deployment.<\/p>\n\n\n\n<p><strong>6. Why is malaria vaccination important for children?<\/strong><br>Children under five are the most vulnerable to malaria. Vaccination can prevent severe illness, hospitalization, and death, particularly in Africa where most cases occur.<\/p>\n\n\n\n<p><strong>7. How does this deal contribute to global health equity?<\/strong><br>By lowering vaccine costs and ensuring wide access, the deal helps bridge gaps between rich and poor countries, making life-saving vaccines available to children in need.<\/p>\n\n\n\n<p><strong>8. How much additional funding is expected to be generated from this deal?<\/strong><br>The agreement is expected to generate <strong>up to US$ 90 million<\/strong> in savings, enabling the purchase of 30 million extra vaccine doses.<\/p>\n\n\n\n<p><strong>9. Which countries are likely to benefit the most?<\/strong><br>African nations with high malaria burden and limited resources are expected to benefit the most, including Nigeria, Ghana, Burkina Faso, and Uganda.<\/p>\n\n\n\n<p><strong>10. How does this deal impact global malaria targets?<\/strong><br>The initiative aligns with Gavi\u2019s goal of vaccinating <strong>50 million children by 2030<\/strong>, contributing to global malaria reduction and child survival targets.<\/p>\n\n\n\n<p><br><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Some_Important_Current_Affairs_Links\"><\/span>Some Important Current Affairs Links<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<div class=\"wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button is-style-outline is-style-outline--1\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/edunovations.com\/currentaffairs\/category\/national\/\" target=\"_blank\" rel=\"noreferrer noopener\">State Current Affairs<\/a><\/div>\n\n\n\n<div class=\"wp-block-button is-style-outline is-style-outline--2\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/edunovations.com\/currentaffairs\/category\/sports\/\" target=\"_blank\" rel=\"noreferrer noopener\">Sports Current Affairs<\/a><\/div>\n\n\n\n<div class=\"wp-block-button is-style-outline is-style-outline--3\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/edunovations.com\/currentaffairs\/category\/international\/\" target=\"_blank\" rel=\"noreferrer noopener\">International Current Affairs<\/a><\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/edunovations.com\/currentaffairs\/category\/banking\/\" target=\"_blank\" rel=\"noreferrer noopener\">Banking Current Affairs<\/a><\/div>\n\n\n\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/edunovations.com\/currentaffairs\/category\/railway\/\" target=\"_blank\" rel=\"noreferrer noopener\">Railways Current Affairs<\/a><\/div>\n\n\n\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/edunovations.com\/currentaffairs\/category\/defence\/\" target=\"_blank\" rel=\"noreferrer noopener\">Defence Current Affairs<\/a><\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button is-style-outline is-style-outline--4\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/edunovations.com\/currentaffairs?newsmaticargs=custom&amp;posts=today\" target=\"_blank\" rel=\"noreferrer noopener\">Daily Current Affairs<\/a><\/div>\n\n\n\n<div class=\"wp-block-button is-style-outline is-style-outline--5\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/edunovations.com\/currentaffairsinhindi\/\" target=\"_blank\" rel=\"noreferrer noopener\">Current Affairs In Hindi<\/a><\/div>\n\n\n\n<div class=\"wp-block-button is-style-outline is-style-outline--6\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/edunovations.com\/currentaffairs\/category\/news-and-notifications\/\" target=\"_blank\" rel=\"noreferrer noopener\">News and Notifications<\/a><\/div>\n<\/div>\n\n\n\n<figure class=\"wp-block-image size-full\"><a href=\"https:\/\/play.google.com\/store\/apps\/details?id=com.edunovations.quiz\" target=\"_blank\" rel=\"noopener\"><img decoding=\"async\" width=\"900\" height=\"150\" src=\"https:\/\/edunovations.com\/currentaffairs\/wp-content\/uploads\/2023\/03\/Banner-current-affairs-2-1.jpg\" alt=\"Download this App for Daily Current Affairs MCQ&#039;s\" class=\"wp-image-247\" title=\"\" srcset=\"https:\/\/edunovations.com\/currentaffairs\/wp-content\/uploads\/2023\/03\/Banner-current-affairs-2-1.jpg 900w, https:\/\/edunovations.com\/currentaffairs\/wp-content\/uploads\/2023\/03\/Banner-current-affairs-2-1-300x50.jpg 300w, https:\/\/edunovations.com\/currentaffairs\/wp-content\/uploads\/2023\/03\/Banner-current-affairs-2-1-768x128.jpg 768w\" sizes=\"(max-width: 900px) 100vw, 900px\" \/><\/a><figcaption class=\"wp-element-caption\">Download this App for Daily Current Affairs MCQ&#8217;s<\/figcaption><\/figure>\n\n\n\n<figure class=\"wp-block-image size-full\" id=\"News-Website-Development-Company\"><a href=\"https:\/\/www.martindiainfotech.com\/\" target=\"_blank\" rel=\"noopener\"><img decoding=\"async\" width=\"900\" height=\"150\" src=\"https:\/\/edunovations.com\/currentaffairs\/wp-content\/uploads\/2023\/04\/News-Website-Development-Company-Banner.png\" alt=\"News Website Development Company\" class=\"wp-image-438\" title=\"News Website Development Company\" srcset=\"https:\/\/edunovations.com\/currentaffairs\/wp-content\/uploads\/2023\/04\/News-Website-Development-Company-Banner.png 900w, https:\/\/edunovations.com\/currentaffairs\/wp-content\/uploads\/2023\/04\/News-Website-Development-Company-Banner-300x50.png 300w, https:\/\/edunovations.com\/currentaffairs\/wp-content\/uploads\/2023\/04\/News-Website-Development-Company-Banner-768x128.png 768w\" sizes=\"(max-width: 900px) 100vw, 900px\" \/><\/a><figcaption class=\"wp-element-caption\">News Website Development Company<\/figcaption><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>Affordable malaria vaccine deal by Gavi and UNICEF reduces R21\/Matrix-M cost to US$ 2.99 per dose, aiming to vaccinate 7 million children and improve global health equity. Gavi &amp; UNICEF Secure Affordable Malaria Vaccine Deal \u2014 What It Means New Pricing Agreement for Malaria VaccineOn 24 November 2025, Gavi, the Vaccine Alliance in partnership with&#8230;<\/p>\n","protected":false},"author":6,"featured_media":42624,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,137],"tags":[30987,2429,30982,1259,30985,25509,2431,30983,935,30984],"class_list":["post-42586","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-international","category-agreements","tag-affordable-vaccines","tag-child-vaccination","tag-gavi","tag-global-health","tag-iffim","tag-malaria-prevention","tag-malaria-vaccine","tag-r21-matrix-m","tag-unicef","tag-vaccine-deal"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/edunovations.com\/currentaffairs\/wp-json\/wp\/v2\/posts\/42586","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/edunovations.com\/currentaffairs\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/edunovations.com\/currentaffairs\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/edunovations.com\/currentaffairs\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/edunovations.com\/currentaffairs\/wp-json\/wp\/v2\/comments?post=42586"}],"version-history":[{"count":3,"href":"https:\/\/edunovations.com\/currentaffairs\/wp-json\/wp\/v2\/posts\/42586\/revisions"}],"predecessor-version":[{"id":42625,"href":"https:\/\/edunovations.com\/currentaffairs\/wp-json\/wp\/v2\/posts\/42586\/revisions\/42625"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/edunovations.com\/currentaffairs\/wp-json\/wp\/v2\/media\/42624"}],"wp:attachment":[{"href":"https:\/\/edunovations.com\/currentaffairs\/wp-json\/wp\/v2\/media?parent=42586"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/edunovations.com\/currentaffairs\/wp-json\/wp\/v2\/categories?post=42586"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/edunovations.com\/currentaffairs\/wp-json\/wp\/v2\/tags?post=42586"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}